Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

Their fortunes depend on successful drug development, which requires allocating all possible ... "Given biotechnology firms have limited revenues, if any, from commercialized products, a lot ...

If these times have anything to say about it, the next Microsoft is coming from the biotech sector. Investors are moving in looking for profits, even putting companies without products on the map.

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

All pre-clinical programs will also be paused. Story Feb. 5 - Viracta Therapeutics: The cancer biotech has closed its doors, laying off all employees and winding down operations. Story Feb. 5 ...

Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology's ability ...

While billions pour into pharmaceutical biotech, officials and experts warn there’s much less private investment in products more relevant to the military, like body armor materials, anti-corrosion ...

The official made the remarks on Tuesday, addressing the 4th International Conference and Exhibition on Iranian Medical Biotech Products and Related Industries (Iran Bio) being held from February 4 to ...

Valerio Therapeutics is ending all clinical trials ... candidate designed to treat recurrent solid tumors. The Paris-based biotech said the decision was made by its board of directors, which ...

The Galien Foundation, which acknowledges “extraordinary scientific innovations that improve the human condition”, has awarded its Best Biotechnology Product 2022 accolade to Regeneron ...